The use of a compound of formula (Ia): wherein A and B are independently selected from a cyclic ring, wherein each of which cyclic rings A and B may be optionally substituted at least one ring position; and L is a suitable linker; or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for use in inhibiting ADP-ribosyl cyclase.
|IPC||A61K31/7084; A61P37/00; (IPC1-7): A61K31/70; A61K31/7084;|
|Publication status||Published - 12 Dec 2002|
Guse, A. H., Mayr, G. W., Potter, B., & Schweitzer , K. (2002). IPC No. A61K31/7084; A61P37/00; (IPC1-7): A61K31/70; A61K31/7084;. Therapeutic compositions for modulating the immune response in a mammal and use thereof. (Patent No. WO02098397A3).